Last reviewed · How we verify
NCT03080948
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
trial testing survey in High-Risk Nevus Phenotype in 73 participants. Completed in 28 November 2025.
28 November 2025
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 73 |
| Start date | 9 March 2017 |
| Primary completion | 28 November 2025 |
| Estimated completion | 28 November 2025 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- survey
- Saliva samples — full drug profile →
Conditions studied
- High-Risk Nevus Phenotype — all drugs for High-Risk Nevus Phenotype →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
18 and older, any sex, with High-Risk Nevus Phenotype. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are doing this study to improve our ability to identify which people with many moles on their skin are most likely to develop skin melanoma. The investigators hope to identify features of moles that are associated with melanoma risk. The investigators hope to use this information to customize and tailor melanoma screening to the individual patient based on a better estimate of their individual risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03080948
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of survey
Trials testing the same drug.
- NCT07340203 — Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation · active not recruiting
- NCT07033390 — Monitor Orthopaedic Footwear Questionnaire (MOS) Validity and Reliability Study · enrolling by invitation
- NCT07012083 — Adherence to Anti-rabies Post-exposure Prophylactic Protocols · completed
- NCT06897865 — Nursing Students Education Virtual Reality Wound Care · not yet recruiting
- NCT06514443 — Barriers and Faciliators for Physical Activity in People With RMDs · not yet recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03080948 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 2 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03080948.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing